A differentiated approach to neurodegenerative biomarker discovery
MiND Biosciences combines molecular diagnostics experience with emerging discoveries in neurodegenerative epigenetics. The approach is differentiated by the integration of multiple molecular layers, including DNA and RNA modification analysis, transcriptomic profiling and biomarker signature development.
Research areas
Multi-layer epigenetic analysis
Habitasse dolor primis id fringilla magnis suscipit vitae tristique imperdiet in natoque.
Integration of DNA, RNA and gene expression data
Habitasse dolor primis id fringilla magnis suscipit vitae tristique imperdiet in natoque.
Focus on blood-based clinical translation
Habitasse dolor primis id fringilla magnis suscipit vitae tristique imperdiet in natoque.
Sequencing-compatible discovery workflows
Habitasse dolor primis id fringilla magnis suscipit vitae tristique imperdiet in natoque.
Disease-relevant biological interpretation
Habitasse dolor primis id fringilla magnis suscipit vitae tristique imperdiet in natoque.
Experienced molecular diagnostics leadership
Habitasse dolor primis id fringilla magnis suscipit vitae tristique imperdiet in natoque.
Partner with us
MiND Biosciences is committed to advancing biomarker discovery through collaboration. We welcome opportunities to work with researchers, clinicians, industry partners and investors who share our vision for earlier, more precise diagnosis.